| Sandoz Pharmaceuticals AG - Ibandronat Sandoz i.v., Injektionslösung |
| 60532 | | 01 | | Ibandronat Sandoz i.v. | | Injektionslösung | | M05BA06 | | Ibandronic Acid | | 29.07.2010 | | |
|
| Composition |
| acidum ibandronicum 3 mg ut natrii ibandronas monohydricus, acidum citricum monohydricum, natrii chloridum, natrii hydroxidum, acidum hydrochloridum concentratum, aqua ad iniectabile q.s. ad solutionem pro 3 ml corresp. natrium 12 mg. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Ibandronic Acid | 3mg / 3ml |
| | BAG: Active Agent | Dose |
|---|
| Ibandronic Acid | 3 mg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Acidum Hydrochloridum Concentratum | | Sodium Chloride | | Sodium Hydroxide |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | syringe(s) | 44.11 | 64.35 | B | SL | No |
|
